Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, UK
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Search for other papers by Avais Jabbar in
Google Scholar
PubMed
Search for other papers by Arjola Bano in
Google Scholar
PubMed
Search for other papers by Lorna Ingoe in
Google Scholar
PubMed
Search for other papers by Peter Carey in
Google Scholar
PubMed
Search for other papers by Shahid Junejo in
Google Scholar
PubMed
Search for other papers by Honey Thomas in
Google Scholar
PubMed
Search for other papers by Caroline Addison in
Google Scholar
PubMed
Search for other papers by David Austin in
Google Scholar
PubMed
Search for other papers by John P Greenwood in
Google Scholar
PubMed
Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Search for other papers by Azfar G Zaman in
Google Scholar
PubMed
thrombus formation ( 2 ). Biomarkers of inflammation such as C-reactive protein (CRP) are strong independent predictors of cardiovascular events ( 3 ). The myocardium is sensitive to minor changes in thyroid function ( 4 ). Triiodothyronine (T3), the
Search for other papers by Luba Freja Michaelsson in
Google Scholar
PubMed
Search for other papers by Bjarke Borregaard Medici in
Google Scholar
PubMed
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jeppe Lerche la Cour in
Google Scholar
PubMed
Search for other papers by Christian Selmer in
Google Scholar
PubMed
Division of Pharmacies and Reimbursement, Danish Health and Medicines Authority, Copenhagen, Denmark
Search for other papers by Michael Røder in
Google Scholar
PubMed
Search for other papers by Hans Perrild in
Google Scholar
PubMed
Search for other papers by Nils Knudsen in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Introduction To prescribe triiodothyronine (T 3 ) as an add-on to levothyroxine (L-T 4 ) treatment or not to prescribe T 3 is a question which is nowadays considered by many physicians. Patients are also seeking alternative treatments of
Search for other papers by Bjarke Borregaard Medici in
Google Scholar
PubMed
Search for other papers by Jeppe Lerche la Cour in
Google Scholar
PubMed
Search for other papers by Luba Freja Michaelsson in
Google Scholar
PubMed
Search for other papers by Jens Oscar Faber in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
, Fadeyev V, Nygaard B, Vanderpump MP: 2012 ETA Guidelines: the Use of L-T 4 + L-T 3 in the treatment of hypothyroidism. Eur Thyroid J 2012;1:55-71. 3 Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L: Thyroxine-triiodothyronine
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
function tests were available and pointed in the direction of neonatal hyperthyroidism with a suppressed serum TSH and triiodothyronine (T3) and thyroxine (T4) levels just below the upper limit of the age-specific reference range [ 6 ] (table 1 ). However
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, the Netherlands
Search for other papers by Eveline Bruinstroop in
Google Scholar
PubMed
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, the Netherlands
Search for other papers by Anne H van der Spek in
Google Scholar
PubMed
Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Introduction Deiodinases The thyroid produces the thyroid hormone, mainly thyroxine (T4) and to a lesser extent tri-iodothyronine (T3). Within the liver, thyroid hormones are transported across the cell membrane by thyroid hormone
Search for other papers by P. Reed Larsen in
Google Scholar
PubMed
Search for other papers by Ann Marie Zavacki in
Google Scholar
PubMed
Introduction When dietary iodine is sufficient, the major product of the thyroid gland is thyroxine (T4) which is secreted at a rate of 10-fold that of 3,5,3′-triiodothyronine (T3) in humans. Thus, a rate-limiting step in thyroid hormone
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Search for other papers by Rudi Steffensen in
Google Scholar
PubMed
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
with combined levo-triiodothyronine (L-T3) + L-T4 preparations [ 6 ]. In the 2012 European Thyroid Association guidelines for the use of L-T4 and L-T3 in the treatment of hypothyroidism, Wiersinga et al. [ 6 ] reviewed 5 cross-over studies [ 7 - 11
Search for other papers by Genfeng Yu in
Google Scholar
PubMed
Search for other papers by Siyang Liu in
Google Scholar
PubMed
Search for other papers by Cheng Song in
Google Scholar
PubMed
Search for other papers by Qintao Ma in
Google Scholar
PubMed
Search for other papers by Xingying Chen in
Google Scholar
PubMed
Search for other papers by Yuqi Jiang in
Google Scholar
PubMed
Search for other papers by Hualin Duan in
Google Scholar
PubMed
Search for other papers by Yajun He in
Google Scholar
PubMed
Search for other papers by Dongmei Wang in
Google Scholar
PubMed
Search for other papers by Heng Wan in
Google Scholar
PubMed
Search for other papers by Jie Shen in
Google Scholar
PubMed
, 14 ). A Chinese study of 264 sarcopenic patients aged 80 years and older found that in a euthyroid population, those with lower levels of free triiodothyronine (FT3) had a higher risk of mortality ( 15 ). An American survey also found the association
Search for other papers by Saeed Sohrabpour in
Google Scholar
PubMed
Search for other papers by Farrokh Heidari in
Google Scholar
PubMed
Search for other papers by Ebrahim Karimi in
Google Scholar
PubMed
Search for other papers by Reza Ansari in
Google Scholar
PubMed
Search for other papers by Ardavan Tajdini in
Google Scholar
PubMed
Search for other papers by Firouzeh Heidari in
Google Scholar
PubMed
ultrasonographies showed bilateral hypoechoic areas in thyroid gland which was suggestive of SAT. Laboratory results showed mildly elevated free thyroxine and free tri-iodothyronine with undetectable thyrotropin. C-reactive protein levels were also slightly elevated
Search for other papers by Yasmine Abdellaoui in
Google Scholar
PubMed
Search for other papers by Dimitra Magkou in
Google Scholar
PubMed
Search for other papers by Sofia Bakopoulou in
Google Scholar
PubMed
Search for other papers by Ramona Zaharia in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
defined by high levels of free thyroxine (FT4) and free triiodothyronine (FT3) with a normal (but inappropriately elevated) level of thyroid-stimulating hormone (TSH) and encompasses all defects that can interfere with the biological activity of a